Schedule Dispatches
Schedule dispatches give a summary of changes coming out in the next month.
This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.
The full Update is available as a PDF(external link)
The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz
September 2026
New Listings
- Atazanavir sulphate (Atazanavir Viatris) cap 150 mg (p’code 2736306) and cap 200 mg (p’code 2736314) – Special Authority – Retail pharmacy
- Calcitriol (Calcitriol Devatis) cap 0.25 mcg (p’code 2730537) and cap 0.5 mcg (p’code 2730545)
- Cyclizine lactate (Cyclizine lactate Medsurge) inj 50 mg per ml, 1 ml ampoule – Up to 10 inj available on a PSO (p’code 2696290)
- Dapsone (Dapsone (Rising)) tab 25 mg – Retail pharmacy – Specialist – No patient co-payment payable (p’code 2736284)
- Enoxaparin sodium – Subsidy by endorsement; can be waived by Special Authority
- Inj 20 mg in 0.2 ml syringe (Clexane) (p’code 2732955)
- Inj 40 mg in 0.4 ml syringe (Clexane) (p’code 2732963)
- Inj 60 mg in 0.6 ml syringe (Clexane) (p’code 2732971)
- Inj 80 mg in 0.8 ml syringe (Clexane) (p’code 2732998)
- Inj 100 mg in 1 ml syringe (Clexane) – Up to 2 inj available on a PSO (p’code 2733005)
- Inj 120 mg in 0.8 ml syringe (Clexane Forte) (p’code 2733013)
- Inj 150 mg in 1 ml syringe (Clexane Forte) (p’code 2733021)
- Montelukast (Montelukast (Sandoz)) tab 4 mg – s29 and wastage claimable (p’code 2735954)
- Naltrexone hydrochloride (Naltrexone-GH) tab 50 mg – Special Authority – Retail pharmacy – s29 and wastage claimable (p’code 2692961)
- Olanzapine (APO-Olanzapine) tab 2.5 mg (p’code 2736152), tab 5 mg (p’code 2736160) and tab 10 mg (p’code 2736179) – Safety medicine; prescriber may determine dispensing frequency – s29 and wastage claimable
- Perindopril tab 2.5 mg (Coversyl 2.5) (p’code 2726491), tab 5 mg (Coversyl 5) (p’code 2726505) and tab 10 mg (Coversyl 10) (p’code 2726513)
- Tamsulosin hydrochloride (Aurobindo Tamsulosin) cap 400 mcg – Special Authority – Retail pharmacy – s29 and wastage claimable (p’code 2735865)
- Water (Multichem) inj 20 ml ampoule – Up to 5 inj available on a PSO (p’code 2208334)
Changes to restrictions, chemical names and presentations
- Dulaglutide (Trulicity) inj 1.5mg per 0.5 ml prefilled pen – amended Special Authority criteria
- Haemophilus influenzae type B vaccine (Act-HIB) inj 10 mcg vial with diluent syringe – amended eligibility criteria
- Hyoscine butylbromide (Spazmol) inj 20 mg, 1 ml ampoule – amended presentation description
- Liraglutide (Victoza) inj 6 mg per ml, 3 ml prefilled pen – amended Special Authority criteria
- Oestradiol (Estradiol TDP Mylan) patch 25 mcg, 50 mcg, 75 mcg and 100 mg per 24 hours – amended presentation description, addition of stat dispensing and ‘Only on a prescription’ rule
- Perindopril – reinstate stat dispensing
- Tab 2 mg (Coversyl)
- Tab 2.5 mg (Coversyl 2.5)
- Tab 4 mg (Coversyl)
- Tab 5 mg (Coversyl 5)
- Tab 8 mg (Coversyl)
- Tab 10 mg (Coversyl 10)
- SGLT2 Inhibitors – amended Special Authority criteria
Increased Subsidy
|
Chemical |
Presentation |
Fully subsidised brands |
|---|---|---|
|
Acitretin |
Cap 10 mg and 25 mg |
Novatretin |
|
Amino acid formula |
Powder, 400 g OP |
Alfamino Alfamino Junior |
|
Amlodipine |
Tab 2.5 mg, 5 mg and 10 mg |
Vasorex |
|
Amoxicillin with clavulanic acid |
Tab 500 mg with clavulanic acid 125 mg |
Curam Duo 500/125 |
|
Anastrozole |
Tab 1 mg |
Anatrole |
|
Atropine sulphate |
Eye drops 1%, 15 ml OP |
Atropt |
|
Benzylpenicillin sodium [Penicillin G] |
Inj 600 mg (1 million units) vial |
Sandoz |
|
Betahistine dihydrochloride |
Tab 16 mg |
Serc |
|
Bisoprolol fumarate |
Tab 5 mg and tab 10 mg |
Ipca-Bisoprolol |
|
Calcium carbonate |
Tab 1.25 g (500 mg elemental) |
Calci-Tab 500 |
|
Captopril |
Oral liq 5 mg per ml, 100 ml OP |
DP-Captopril |
|
Cefazolin |
Inj 500 mg vial |
Cefazolin-AFT |
|
Cetirizine hydrochloride |
Oral liq 1 mg per ml, 200 ml |
Histaclear |
|
Clonidine
|
Patch 2.5 mg, 100 mcg per day Patch 5 mg, 200 mcg per day Patch 7.5 mg, 300 mcg per day |
Mylan |
|
Diabetic oral feed 1kcal/ml |
Liquid (vanilla), 200 ml bottle |
Nutren Diabetes |
|
Docusate sodium |
Tab 50 mg and 120 mg |
Coloxyl |
|
Donepezil hydrochloride |
Tab 5 mg and 10 mg |
Ipca-Donepezil |
|
Escitalopram |
Tab 10 mg and 20 mg |
Ipca-Escitalopram |
|
Finasteride |
Tab 5 mg |
Ricit |
|
Glucose [Dextrose] |
Inj 50%, 10 ml ampoule |
Biomed |
|
Hydroxyurea [Hydroxycarbamide] |
Cap 500 mg |
Devatis |
|
Indapamide |
Tab 2.5 mg |
Dapa-Tabs |
|
Isosorbide mononitrate |
Tab long-acting 60 mg |
Duride |
|
Hydrocortisone and paraffin liquid and lanolin |
Lotn 1% with paraffin liquid 15.9% and lanolin 0.6%, 250 ml |
DP Lotn HC |
|
Hyoscine butylbromide |
Inj 20 mg, 1 ml ampoule |
Spazmol |
|
Lamivudine |
Tab 100 mg |
Zetlam |
|
Lamivudine |
Tab 150 mg |
Lamivudine Viatris |
|
Nystatin |
Oral liq 100,000 u per ml, 24 ml OP |
Nilstat |
|
Nystatin |
Vaginal crm 100,000 u per 5 g with applicator(s), 75 g OP |
Nilstat |
|
Oral elemental feed 1kcal/ml |
Powder (unflavoured), 80 g sachet |
Vivonex TEN |
|
Oral feed (powder)
|
Powder (chocolate) and powder (vanilla), 840 g OP |
Sustagen Hospital Formula |
|
Paracetamol |
Suppos 125 mg, 250 mg and 500 mg |
Gacet |
|
Peptide-based oral feed |
Powder, 400 g OP |
Peptamen Junior |
|
Pine tar with trolamine laurilsulfate and fluorescein |
Soln 2.3% with trolamine laurilsulfate and fluorescein sodium, 500 ml |
Pinetarsol |
|
Poloxamer |
Oral drops 10%, 30 ml OP |
Coloxyl |
|
Potassium iodate |
Tab 253 mcg (150 mcg elemental iodine) |
NeuroTabs |
|
Protein supplement |
Powder, 227 g OP |
Resource Beneprotein |
|
Renal oral feed 2 kcal/ml |
Liquid, 200 ml bottle, 4 OP |
NovaSource Renal |
|
Temazepam |
Tab 10 mg |
Normison |
|
Terbinafine |
Tab 250 mg |
Deolate |
|
Testosterone undecanoate |
Cap 40 mg |
Steril-Gene |
|
Vitamin B complex |
Tab, strong, BPC |
Bplex |
Decreased Subsidy
|
Chemical |
Presentation |
Fully subsidised brands |
|---|---|---|
|
Bortezomib |
Inj 1 mg for ECP |
Baxter |
|
Paraffin |
White soft, 450 g |
EVARA White Soft Paraffin |
|
Ursodeoxycholic acid |
Cap 250 mg |
Ursosan |